KTTA
Pasithea Therapeutics Corp.
$0.68-0.01 (-1.45%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Pasithea Therapeutics Corp. (KTTA) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 12 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-11-28 | Schneiderman Daniel H | CFO | Award | 26,667 | $0.75 | $20,000 | N/A | N/A |
| 2025-12-01 | 2025-11-28 | Leahy Emer | Director | Award | 33,333 | $0.75 | $25,000 | N/A | N/A |
| 2025-12-01 | 2025-11-28 | Marques Tiago | CEO | Purchase | 33,333 | $0.75 | $25,000 | +50.7% | +52.0% |
| 2025-12-01 | 2025-11-28 | Dumesnil Simon | Director | Purchase | 33,333 | $0.75 | $25,000 | +50.7% | +52.0% |
| 2025-12-01 | 2025-11-28 | Steinman Lawrence | Director | Purchase | 133,333 | $0.75 | $100,000 | +50.7% | +52.0% |
| 2025-10-27 | 2025-10-24 | Novak Alfred J | Director | Award | 42,913 | $0.00 | $0 | N/A | N/A |
| 2025-10-27 | 2025-10-24 | Steinman Lawrence | Director | Award | 242,913 | $0.00 | $0 | N/A | N/A |
| 2025-10-27 | 2025-10-24 | Marques Tiago | CEO | Award | 493,341 | $0.00 | $0 | N/A | N/A |
| 2025-10-27 | 2025-10-24 | Dumesnil Simon | Director | Award | 42,913 | $0.00 | $0 | N/A | N/A |
| 2025-10-27 | 2025-10-24 | Schneiderman Daniel H | CFO | Award | 317,266 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.